BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021

NEXT STORY
Biofidelity appoints Stephen Miller as Chief Commercial Officer
PREV STORY
New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted

Oasmia Pharmaceutical AB (Nasdaq: OASM) announces that the United States Patent and Trademark Office ...

author_avatar
NASDAQ Market News

Genedrive PLC: Commercial sales of Genedrive® HCV ID Kit and platform begin

13 March 2018 genedrive plc ("genedrive" or the "Company") Commercial sales of Genedrive® HCV ...

author_avatar
NASDAQ Market News

Terveystalo Plc: Notice of the Annual General Meeting

Terveystalo Plc Stock Exchange Release 14 February 2019 at 9:05 EET Notice is given ...

author_avatar
NASDAQ Market News